Tuesday, 20th May AUS-oMicS 2025

Thermo Breakfast Workshop - Advancing Biomedical Research and Diagnostics with Orbitrap Astral Mass Spectrometer

Presenters:

• Darren Creek, Director, Drug Target Identification Node, Monash Proteomics and Metabolomics Facility: Throughput and coverage of Orbitrap Astral Mass Spectrometer to advance chemo proteomics studies for drug discovery
• Tanavi Sharma, Research Officer in Clinical Proteomics, Bio21: Evaluating the Performance of the Orbitrap Astral Mass Spectrometer for Diagnosis of Rare Diseases

• Infrared Spectroscopy in a Mass Spectrometer – Molecular Fingerprints for Omics Research - Kevin Pagel

• Structural Homology Analysis Identifies New Substrates of the Protein O-fucosyltransferases FUT10 and FUT11 - Mark Larance
• Enhancing Glycopeptide Identification: Comparative Analysis of Orbitrap Mass Spectrometers - Amanda Lee
• Mass spectrometry and HPC: the time is now! - Johan Gustafsson
• Informatics solutions to characterise glycopeptides in the class I immunopeptidome - Joshua Fehring
• Multi-omics data integration of the pan wheat cultivars reveal plasticity in drought response - Angela Juhasz

• Glycomic Alterations in Breast Cancer Tissues Following Pre-operative Oral Carbohydrate Intake - Arun Everest-Dass

Thermo Lunchtime Workshop - Automated Multi-Omics Integration and Advances in Glycomic Quantification

Presenters:

• Arun Everest-Dass,Research Leader Advanced Queensland Senior Research Fellow, Grifith University: Overcoming Glycomic Quantification Challenges
• Subash Adhikari, Research Officer in Clinical Multi-Omics, Biochemistry and Pharmacology, Bio21: OMIX3, an automated multi-omics platform for integrated proteomics, metabolomics and lipidomics analysis of clinical samples

• Defining the role of lipid metabolism in bridging diet and metabolic health - Peter J Meikle

• Characterising Chemical Complexity Using Ion Mobility Mass Spectrometry  - Nicole J Rijs

• Spatial proteomics of murine colon cancer using mass spectrometry imaging - Samuel T Gould
• Large-scale protein-disease risk association analysis in the UK Biobank: Introducing an extensive and freely available research resource in Olink® Insight - Renu Balyan
• Elucidating the Mechanism of 2-Aminobenzimidazole Antimalarials Through Mass Spectrometry-Based Target Deconvolution - Eileen Yunyang Zhou

• Resolution and characterisation of isomeric coordination complexes with high-resolution ion mobility mass spectrometry - David Marshall
• Unimolecular Decomposition of Deprotonated Glyphosate: Ion Mobility Mass Spectrometry to Discern Cyclic versus Linear Dehydration Products - Olivia Rusli
• Release and Identification of Feruloylated Oligosaccharides from Brewers Spent Grains Using Deep Eutectic Solvents and Ion Mobility Mass Spectrometry - David Nkurunziza

• Beyond the Sequon: Modulation of N-Glycosylation Site Occupancy - Ben Schulz
• GlyCage: IgG N-glycosylation cardiovascular age tracks cardiovascular health beyond calendar age - Wei Wang
• Profiling candidate genes coding family 1 UDP-glycosyltransferase involved in glycosylating exogenous volatile phenols using Arabidopsis thaliana as a model plant. - Maddy MJ Jiang

• Quantitative analysis and structural characterization of bile acids using the ZenoTOF 7600 system - Thusi Rupasinghe
• Metabolomics and Virtual Screening Reveal Potential Drug Targets to Combat Trichinella spiralis Albendazole Resistance - Peerut Chienwichai
• Effects of short-term exercise on plasma metabolic and lipidomic profiles of individuals with type 2 diabetes - Nathan G Lawler

• Leveraging AI to Enhance and Democratize Mass Spectrometry-Based Omics Data Interpretation - Aivett Bilbao